The elucidation of the physiologic function of rare sugar and the exploitation of prophylactic drug for necrotizing enterocolitis
Project/Area Number |
17K10180
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Embryonic/Neonatal medicine
|
Research Institution | Kagawa University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
藤井 喬之 香川大学, 医学部, 助教 (00746696)
田中 彩 (西村彩) 香川大学, 医学部, 助教 (30459200)
形見 祐人 香川大学, 医学部附属病院, 助教 (50791224)
加治 建 鹿児島大学, 鹿児島大学病院, 特任教授 (50315420)
家入 里志 鹿児島大学, 医歯学域医学系, 教授 (00363359)
|
Project Period (FY) |
2017-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 壊死性腸炎 / 短腸症候群 / 栄養障害 / 腸内細菌叢 / 細胞保護 / Guar Gum / 腸内フローラ / 医療・福祉 / 細胞・組織 / 応用微生物 |
Outline of Final Research Achievements |
We investigated whether PHGG ameliorates small intestinal mucosal damage and alters the intestinal microbiota using a rat small bowel resection (SBR) model. Sprague Dawley rats were divided into sham operation (Sham), Sham/PHGG, SBR, and SBR/PHGG groups. On day 21, all rats were euthanized. To assess small intestinal mucosal damage, the degeneration rate was morphometrically evaluated and immunohistochemically examined using anti-CD45 antibodies. Analyses of fecal microbiota using 16S rRNA and short-chain fatty acid production were also performed. The mucosal degeneration rate was significantly higher in the SBR group than in the Sham or SBR/PHGG groups. The number of CD45-positive cells was significantly higher in the SBR group than in the Sham, Sham/PHGG, or SBR/PHGG groups. PHGG administration alleviated small intestinal mucosal damage which could be associated with modulation of the intestinal microbiota.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究に使用した水溶性食物繊維Guar Gum (PHGG)はすでに市販されており、希少糖と同様に抗炎症作用による細胞保護作用があることが分かった。薬剤ではないため、短腸症候群のみならず、炎症性腸疾患にも応用がしやすいと思われた。
|
Report
(5 results)
Research Products
(25 results)
-
-
-
-
-
-
-
-
[Journal Article] Partially hydrolyzed guar gum improves small intestinal mucosal damage after massive small bowel resection along with the change of intestinal microbiota2019
Author(s)
Takayuki Fujiia, Yoichi Chibab, Haruyuki Nakayama-Imaohjic, Shun Onishid, Aya Tanakaa, Hiroto Katamia, Tatsuru Kajid, Satoshi Ieirid, Takanori Mikie, Masaki Uenob, Tomomi Kuwaharac, Ryuichi Shimono
-
Journal Title
Journal of Pediatric Surgery
Volume: in press
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Nutritional Benefit of Recycling of Bowel Content in an Infant With Short Bowel Syndrome.2017
Author(s)
Tanaka A, Nakayama-Imaohji H, Shimono R, Suzuki M, Fujii T, Kubo H, Yasuda S, Koyano K, Nakamura S, Katsuki N, Kuwahara T.
-
Journal Title
J Pediatr Gastroenterol Nutr.
Volume: 65
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Partially hydrolyzed guar gum improves small intestinal mucosal damage after massive small bowel resection along with the change of intestinal microbiota2019
Author(s)
Takayuki Fujiia, Yoichi Chibab, Haruyuki Nakayama-Imaohjic, Shun Onishid, Aya Tanakaa, Hiroto Katamia, Tatsuru Kajid, Satoshi Ieirid, Takanori Mikie, Masaki Uenob, Tomomi Kuwaharac, Ryuichi Shimono
Organizer
52nd nnual Scientific Meeting of the Pacific Association of Pediatric Surgeons 2019
Related Report
Int'l Joint Research
-
-
-
-
-
-
[Book] 小児臨床栄養学2018
Author(s)
日本小児栄養消化器肝臓学会、下野隆一、田中彩、他
Total Pages
509
Publisher
診断と治療社
ISBN
9784787823397
Related Report